Crystalgenomics, Inc.

République de Corée


 
Quantité totale PI 55
Rang # Quantité totale PI 24 893
Note d'activité PI 2,1/5.0    18
Rang # Activité PI 46 436
Symbole boursier 083790 (kosdaq)
ISIN KR7083790006
Capitalisation 184.5B  (KRW)
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

14 0
9 0
31 1
0
 
Dernier brevet 2023 - Pharmaceutical composition, comp...
Premier brevet 2004 - Glycogen synthase kinase 3β inhi...
Dernière marque 2017 - Acelex
Première marque 2017 - Acelex

Industrie (Classification de Nice)

Derniers inventions, produits et services

2023 Invention Pharmaceutical composition for treating acute and chronic pain, containing polmacoxib and tramado...
Invention Pharmaceutical composition, comprising polmacoxib and pregabalin, for treatment of pain. The pre...
2022 Invention 2,3-dihydro-isoindole-1-on derivative as btk kinase suppressant, and pharmaceutical composition i...
Invention Methods for treating patients with hematologic malignancies. The present disclosure comprises a ...
2021 Invention Pharmaceutical composition for preventing or treating severe acute respiratory syndrome coronavir...
2020 Invention Pharmaceutical composition comprising hdac inhibitor and anti-pd1 antibody or anti pd-l1 antibody...
Invention 2,3-dihydro-isoindole-1-one derivative as btk kinase suppressant, and pharmaceutical composition ...
Invention Injection composition containing fab i inhibitor, and preparation method therefor. The present i...
Invention Injection composition containing fab i inhibitor, and preparation method therefor. The present in...
2019 Invention Pharmaceutical composition containing alkyl carbamoyl naphthalenyloxy octenoyl hydroxyamide phosp...
Invention 7-hydroxy-4h-thieno[3,2-b]pyridin-5-on derivative and use thereof. Provided in the present invent...
Invention Orally administered pharmaceutical composition comprising fab i inhibitors and method for prepari...
Invention Pharmaceutical composition for prevention or treatment of fibrosis. The present invention relate...
Invention Pharmaceutical composition for prevention or treatment of fibrosis. The present invention relates...
Invention Pharmaceutical composition, comprising polmacoxib and pregabalin, for treatment of pain. The pres...
Invention Transdermal absorption preparation. The present invention relates to a transdermal absorption pre...
Invention Polmacoxib-containing injection composition having excellent stability and preparation method the...
2018 Invention Pharmaceutically acceptable salt of alkylcarbamoyl naphthalenyloxy octenoylhydroxy amide or of de...
Invention Pharmaceutically acceptable salt of alkylcarbamoyl naphthalenyloxy octenoylhydroxyamide or of der...
Invention Methods for treating patients with hematologic malignancies. The present disclosure comprises a m...
2017 P/S Analgesic preparations; pain relief preparations; topical analgesics; anti-inflammatory preparat...
Invention Oral pharmacological composition including 5-{4-(amino sulfonyl)phenyl}-2,2-dimethyl-4-(3-fluorop...
2016 Invention Pharmaceutical composition comprising potassium salt of telmisartan, and preparation method there...
2015 Invention Pharmaceutical composition including 5--2,2-dimethyl-4-(3-fluorophenyl)-3(2h)-furanone and capsul...
Invention Pharmaceutical composition including 5-{4-(aminosulfonyl)phenyl}-2,2-dimethyl-4-(3-fluorophenyl)-...
2013 Invention 2,3-dihydro-isoindol-1-one derivatives and methods of use thereof as btk inhibitor. The pre...
2011 Invention 2,3-dihydro-isoindol-1-one derivative and a composition comprising the same. The present inventio...
Invention Novel aminoquinazoline compound having a protein-kinase inhibiting action. The present invention ...
Invention Azaindole derivative. The present invention provides a (di)azaindole derivative represented by t...
Invention Azaindole derivative. The present invention provides a (di)azaindole derivative represented by th...
Invention Novel benzimidazole compound, preparation method thereof and pharmaceutical composition comprisin...